DarioHealth (NASDAQ:DRIO) & ADB International Group (OTCMKTS:EQUR) Financial Analysis

DarioHealth (NASDAQ:DRIO) and ADB International Group (OTCMKTS:EQUR) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, valuation, analyst recommendations and institutional ownership.

Earnings & Valuation

This table compares DarioHealth and ADB International Group”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DarioHealth	$22.36 million	2.56	-$41.71 million	($8.88)	-0.88
ADB International Group	N/A	N/A	N/A	N/A	N/A

ADB International Group has lower revenue, but higher earnings than DarioHealth.

Institutional & Insider Ownership

33.4% of DarioHealth shares are held by institutional investors. 3.5% of DarioHealth shares are held by company insiders. Comparatively, 79.6% of ADB International Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares DarioHealth and ADB International Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
DarioHealth	-192.23%	-60.52%	-37.08%
ADB International Group	N/A	N/A	N/A

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for DarioHealth and ADB International Group, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DarioHealth	1	1	1	0	2.00
ADB International Group	0	0	0	0	0.00

DarioHealth presently has a consensus target price of $10.50, indicating a potential upside of 34.79%. Given DarioHealth’s stronger consensus rating and higher probable upside, equities research analysts clearly believe DarioHealth is more favorable than ADB International Group.

Summary

DarioHealth beats ADB International Group on 5 of the 9 factors compared between the two stocks.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

About ADB International Group

E-Qure Corp., a medical device company, focuses on the development and commercialization of bioelectrical signal therapy (BST) devices. Its BST devices implement patented and proprietary electrical stimulation technologies to treat hard-to-cure wounds and ulcers up to complete closure and/or cure. The company was incorporated in 1988 and is based in New York, New York.